RSS Feeds
Search

Press releases

Press releases

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Respiratory Syncytial Virus (RSV) Infection Therapy Area Pipeline Report
Nov 2010 - 160 pages - $1,495
Respiratory Syncytial Virus (RSV) Infection - Pipeline Review, Q1 2011
Jan 2011 - 33 pages - $500
Respiratory Syncytial Virus (RSV) Infection Global Clinical Trials Review, Q4, 2010
Dec 2010 - 48 pages - $1,000
Respiratory Syncytial Virus (Rsv) Infection - Pipeline Review, Q3 2011
Jul 2011 - 82 pages - $500
Stakeholder Opinions: Respiratory viral infections - Respiratory syncytial virus, parainfluenza virus and human metapneumovirus as promising new targets
Apr 2010 - 139 pages - $3,800
West Nile Virus Global Clinical Trials Review, Q1, 2011
Apr 2011 - 24 pages - $1,000
Stakeholder Opinions: Biologics in Infectious Diseases Well defined target populations are key to commercial success
Mar 2008 - 123 pages - $3,800
What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline
Feb 2010 - 220 pages - $4,200
Epidemiology: Hepatitis C - Hepatitis C virus will remain a prevalent bloodborne disease in the seven major markets, primarily transmitted through injection drug use
Feb 2011 - 26 pages - $5,700
Innovations in Molecular Diagnostics for Infectious Diseases
Nov 2011 - 168 pages - $3,835
More Related Market Research Reports >>>

Your selection

Therapeutic target
Infectious diseases del
Bacteria or virus del
Respiratory syncytial virus RSV del
Year
2009 del

Browse By

Industry sector
Academic/Research
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Non-profit org./Government
Pharmaceutical
Research tools
Service

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us